Today: 24.Feb.2018
Radioisotopes and Nuclear Medicine
Radioisotopes and Nuclear Medicine (84)

03.Feb.2018 Written by

Society of Nuclear Medicine and Molecular Imaging: A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11).

30.Dec.2017 Written by

CRC Press, Edited by Michael Poeschl and Leo M. L. Nollet: A comprehensive, fairly easy to read and understand treatise by 31 experts from around the world on the exciting topics of radionuclides, radiation, radioactivity and their presence and uses in the environment and food. Contributors and Editors are from Australia, Belgium, Czech Republic, England, Italy, Portugal, Saudi Arabia, Slovakia, Spain, Switzerland, and the USA. Topics: What are Radionuclides, Sources, Radioactivity in the Air, in Water, in Soils, Transport Processes and Modeling, in Foodstuffs and Food Raw Material, Radiation Detection Methods, Unmasking Illicit Trafficking of Nuclear and Radioactive Materials, Radiation Protection, Regulations, Food Irradiation.

28.Oct.2017 Written by

Leonne Prompers, Medical manager, nuclear medicine Physician bij Zuyderland: EANM Brochure - Principles and Practice of PET/CT, Part 2 A Technologist's Guide with 41 contributing authors. Principles of PET radiochemistry. Clinical applications of PET/CT in oncology. Clinical applications of PET/CT in infection and inflammation. Clinical applications of PET/CT in cardiology. Clinical applications of PET/CT in neurology.

28.Oct.2017 Written by

Bernard Songy, Médecin, Cardiologie nucléaire, David Lussato, M.D., Mohamed Guernou, Médecin nucléaire, Gil Kovalski Ph.D. Biomedical Engineering: Description of nuclear medicine practice at Centre Cardiologique du Nord, (CCN) Paris, France.

12.Oct.2017 Written by

European Association of Nuclear Medicine: Many people associate the term, nuclear medicine, with dangerous radiation. These concerns are unfounded. While it is true that radioactive substances are used, the exposure doses to the patient are so low according to the European Association of Nuclear Medicine (EANM) that they do not call into question the benefits of the diagnostic and therapeutic possibilities of nuclear medicine.

06.Aug.2017 Written by

José Pascual Pérez Campos y Eduardo Larrea y Richerand han realizado una muy cuidadosa reseña histórica del desarrollo en México de uno de los grandes avances de la tecnología médica de este siglo. El impacto de estas tecnologías en el diagnóstico y tratamiento de las enfermedades ha modificado favorablemente la atención de numerosas enfermedades. Los conocimientos que sirvieron de base para crear armas de destrucción masiva, afortunadamente para la conciencia de los investigadores de este campo, se han convertido en un arma eficaz en beneficio de los enfermos. El grupo de científicos de Oak Ridge asociados con investigadores de diversas universidades lograron avanzar de los iniciales usos del Yodo para el diagnóstico y tratamiento de enfermedades del tiroides a diversos implementos tecnológicos que han permitido estudiar el cuerpo humano con una precisión increíble.

04.Aug.2017 Written by

Dr. Rodrigo Muñoz Casillas, Dra. Nora E. Kerik Rotenberg, Dr. Iván Eudaldo Díaz Meneses, M. en C. Carlos Alberto Reynoso Mejía. Instituto Nacional de Neurología y Neurocirugía “Manuel Velazco Suárez”: La Tomografía por Emisión de Positrones (PET) es la técnica de diagnóstico por imagen de medicina nuclear en la cual se aplica al paciente un radiofármaco (unión de un fármaco con farmacocinética conocida a un átomo radiactivo emisor de positrones). La PET/CT cerebral con 18F-FDG (análogo de la glucosa) evalúa el metabolismo glucolítico cerebral ya que éste proporciona aproximadamente el 95% del ATP necesario para la función cerebral.

31.Jul.2017 Written by

IAEA, International Energy Agency, Jeremy Li: As the major research reactors that supply Mo-99 age and cease production, the alternative method discussed in the paper offers a simplified way to diversify production and help ensure continued supplies of Mo-99 so that nuclear medicine services are not interrupted. In 2009, reactors producing Mo-99 in Canada and the Netherlands were temporarily shut down for necessary repairs and maintenance. This caused major disruption in health care services worldwide, leading to cancelled medical scans and postponed operations, and in some cases requiring medical professionals to revert back to using old, less effective techniques.

31.Jul.2017 Written by

IAEA, International Energy Agency: The Mo 99 supply chain will continue to remain fragile as long as it continues to rely on the same five aged production reactors. Given the way the supply chain has evolved --- particularly its reliance on only five multipurpose, non-commercial, government supported research reactors --- there are no clear market incentives to prompt new capacity or alternative supplies. No date on this document, but references indicate that it is 2009 or more recent.

30.Jul.2017 Written by

World Nuclear News, Gene Cramer: Update on production of Molybdenum 99 in the United States. A license amendment request has been submitted to the US Nuclear Regulatory Commission to allow the University of Missouri Research Reactor to produce medical isotope molybdenum-99, partners MURR, Nordion and General Atomics announced yesterday. Once operational, production from MURR will be capable of meeting nearly half of US demand for the isotope, which is currently imported from outside North America. Nordion expects to start receiving Mo-99 from MURR in mid- to late-2018. Technetium-99m is a nuclear isomer of technetium-99. It is known as the most commonly used medical radioisotope because of its use in tens of millions of medical procedures annually.

Newsletter Subscription

  • Latest
  • Popular
  • Thomas Cochran has been working with the…
  • Charles Barton, lead advocate for advanced nuclear…
  • Rod Adams, Atomic energy expert with small…
  • Neil Alexander, Ph.D. radiation damage in steels,…
  • Neil Alexander, Ph.D. radiation damage in steels,…
  • Thomas Cochran has been working with the…
  • Charles Barton, lead advocate for advanced nuclear…